| MULTIPLE SCLEROSIS IN
THE 21st CENTURY
Saturday, December 7, 2002
Overview
Course Description
This one-day course will review the neuronal damage and axonal loss
which are the basis of MS pathology. Fred D. Lublin, MD, the course
director, has been instrumental in the recent identification of new
criteria for diagnosing MS. The culmination of new guidelines will be
discussed. Insight will be provided into the use of disease modifying
techniques and therapies, as well as into the use and interpretation
of MRIs for disease management. Furthermore, the course will identify
opportunities for neurology residents in the field of MS.
Objectives
At the conclusion of this course, participants will:
- Be able to identify current diagnostic criteria for MS.
- Understand MS immunopathogenesis as it relates to therapeutic intervention.
- Understand the basis for selecting and instituting therapy management
techniques.
- Be able to implement state of the art techniques for the management
of MS symptoms.
- Have a perspective on the role of the private practitioner in an
MS Center.
Who Should Attend?
This course is designed for neurology residents, neurologists, and anyone
interested in the field of neurology and MS in particular.
Faculty Disclosure Statement
It is the policy of the Mount Sinai School of Medicine to ensure fair
balance, independence, objectivity, and scientific rigor in all its
sponsored programs. All faculty participating in sponsored programs
are expected to disclose to the audience any real or apparent conflict-of-interest
related to the content of their presentation, and any discussions of
unlabeled or investigational use of any commercial product or device
not yet approved in the United States.
Accreditation
This activity has been planned and implemented in accordance with the
Essentials and Standards of the Accreditation Council for Continuing
Medical Education (ACCME) through the sponsorship of Mount Sinai School
of Medicine. Mount Sinai School of Medicine is accredited by ACCME to
provide continuing medical education for physicians. Mount Sinai School
of Medicine designates this continuing medical education activity for
a maximum of 7 credits in Category 1 credit towards the AMA Physician's
Recognition Award. Each physician should claim only those hours that
he/she spent in the educational activity.
Special Needs
Mount Sinai School of Medicine fully complies with the legal requirements
of the Americans with Disabilities Act and the rules and regulations
thereof. Participants with special needs are requested to contact the
Page and William Black Post-Graduate School of Medicine at 212.241.6737.
Hatch Auditorium
Mount Sinai School of Medicine
1468 Madison Avenue
New York, NY 10029
Financial Support
Funding for this program is provided by an unrestricted educational
grant from Teva Neuroscience.
|
